{
    "eid": "2-s2.0-85082771875",
    "title": "The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases",
    "cover-date": "2020-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Acute kidney injury",
        "GNF-7",
        "Necroptosis",
        "RIPK1",
        "RIPK3"
    ],
    "authors": [
        "Xia Qin",
        "Longmiao Hu",
        "Shen nan Shi",
        "Xiaofei Chen",
        "Chunlin Zhuang",
        "Wen Zhang",
        "Siriporn Jitkaew",
        "Xiufeng Pang",
        "Jianqiang Yu",
        "Ye xiong Tan",
        "Hong yang Wang",
        "Zhenyu Cai"
    ],
    "citedby-count": 17,
    "ref-count": 47,
    "ref-list": [
        "Execution of RIPK3-regulated necrosis",
        "Necroptosis and its role in inflammation",
        "Necroptosis",
        "The molecular machinery of regulated cell death",
        "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation",
        "Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha",
        "RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis",
        "Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis",
        "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase",
        "Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis",
        "Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3",
        "Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death",
        "MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates",
        "Necroptosis: mechanisms and relevance to disease",
        "Necroptosis signaling in liver diseases: an update",
        "Acute kidney injury",
        "Nonapoptotic cell death in acute kidney injury and transplantation",
        "Necroptosis in acute kidney injury",
        "A role for tubular necroptosis in cisplatin-induced AKI",
        "Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury",
        "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury",
        "Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3",
        "Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4-c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships",
        "Structural insights into RIP3-mediated necroptotic signaling",
        "Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives",
        "Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway",
        "Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search",
        "Mouse model of ischemic acute kidney injury: technical notes and tricks",
        "Differential roles of macrophages in diverse phases of skin repair",
        "Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1",
        "A type-II kinase inhibitor capable of inhibiting the T315I \u201cgatekeeper\u201d mutant of Bcr-Abl",
        "A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis",
        "Target identification using drug affinity responsive target stability (DARTS)",
        "N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d] thiazol-2-yl)cyclopropanecarboxamide (TAK-632) analogues as novel necroptosis inhibitors by targeting receptor-interacting protein kinase 3 (RIPK3): synthesis, structure-activity relationships, and in vivo efficacy",
        "Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice",
        "F4/80, a monoclonal antibody directed specifically against the mouse macrophage",
        "Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture",
        "Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family",
        "Generation of small molecules to interfere with regulated necrosis",
        "Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors",
        "Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach",
        "Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phe nyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a potent, selective, and orally available BCR-ABL/SRC/p38 kinase inhibitor for chronic myeloid leukemia",
        "Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-Abl(T315I) mutant",
        "First SAR study for overriding NRAS mutant driven acute myeloid leukemia",
        "Tozasertib analogues as inhibitors of necroptotic cell death",
        "Programmed necrosis in acute kidney injury",
        "A systematic review of strategies to prevent cisplatin-induced nephrotoxicity"
    ],
    "affiliation": [
        {
            "affiliation-city": "Shanghai",
            "@id": "60025234",
            "affilname": "Second Military Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60129180",
            "affilname": "Tongji University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60108904",
            "affilname": "Fudan University Shanghai Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108904",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60021200",
            "affilname": "East China Normal University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021200",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Yinchuan",
            "@id": "60017763",
            "affilname": "Ningxia Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017763",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60009860",
            "affilname": "Fudan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860",
            "affiliation-country": "China"
        }
    ],
    "funding": [
        "China's 1000 Young Talents Program",
        "China\u2019s 1000 Young Talents Program",
        "Shanghai International Cooperation and Exchange Project",
        "China Association for Science and Technology",
        "Key Research and Development Program of Ningxia",
        "National Natural Science Foundation of China"
    ]
}